ID   CHPT1_RAT               Reviewed;         398 AA.
AC   Q66H21;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   24-JUL-2024, entry version 122.
DE   RecName: Full=Cholinephosphotransferase 1 {ECO:0000305};
DE            EC=2.7.8.2 {ECO:0000250|UniProtKB:Q8WUD6};
DE   AltName: Full=Diacylglycerol cholinephosphotransferase 1;
GN   Name=Chpt1 {ECO:0000312|RGD:1359283}; Synonyms=Cpt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the final step of de novo phosphatidylcholine (PC)
CC       synthesis, i.e. the transfer of choline phosphate from CDP-choline to
CC       the free hydroxyl of a diacylglycerol (DAG), producing a PC. It thereby
CC       plays a central role in the formation and maintenance of vesicular
CC       membranes. {ECO:0000250|UniProtKB:Q8WUD6}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + CDP-choline = a 1,2-diacyl-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:32939,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:57643,
CC         ChEBI:CHEBI:58779, ChEBI:CHEBI:60377; EC=2.7.8.2;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32940;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + CDP-choline = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:54344,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58779, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:74965, ChEBI:CHEBI:75728;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54345;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + CDP-choline =
CC         1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + CMP
CC         + H(+); Xref=Rhea:RHEA:54244, ChEBI:CHEBI:15378, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:73001, ChEBI:CHEBI:75466;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54245;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycerol + CDP-choline = 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
CC         docosahexaenoyl)-sn-glycero-3-phosphocholine + CMP + H(+);
CC         Xref=Rhea:RHEA:54332, ChEBI:CHEBI:15378, ChEBI:CHEBI:58779,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:74963, ChEBI:CHEBI:82949;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54333;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dioctanoyl-sn-glycerol + CDP-choline = 1,2-dioctanoyl-sn-
CC         glycero-3-phosphocholine + CMP + H(+); Xref=Rhea:RHEA:54232,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58779, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:76979, ChEBI:CHEBI:78228;
CC         Evidence={ECO:0000250|UniProtKB:Q4KLV1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54233;
CC         Evidence={ECO:0000250|UniProtKB:Q4KLV1};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q8WUD6};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis;
CC       phosphatidylcholine from phosphocholine: step 2/2.
CC       {ECO:0000250|UniProtKB:Q8WUD6}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q8WUD6}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8WUD6}.
CC   -!- SIMILARITY: Belongs to the CDP-alcohol phosphatidyltransferase class-I
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC082074; AAH82074.1; -; mRNA.
DR   RefSeq; NP_001007751.1; NM_001007750.1.
DR   AlphaFoldDB; Q66H21; -.
DR   SMR; Q66H21; -.
DR   STRING; 10116.ENSRNOP00000072444; -.
DR   PhosphoSitePlus; Q66H21; -.
DR   PaxDb; 10116-ENSRNOP00000007305; -.
DR   Ensembl; ENSRNOT00000080939.2; ENSRNOP00000072444.1; ENSRNOG00000058271.2.
DR   UCSC; RGD:1359283; rat.
DR   AGR; RGD:1359283; -.
DR   RGD; 1359283; Chpt1.
DR   eggNOG; KOG2877; Eukaryota.
DR   GeneTree; ENSGT00950000183117; -.
DR   HOGENOM; CLU_035066_1_0_1; -.
DR   InParanoid; Q66H21; -.
DR   OrthoDB; 5482983at2759; -.
DR   PhylomeDB; Q66H21; -.
DR   TreeFam; TF313270; -.
DR   Reactome; R-RNO-1483191; Synthesis of PC.
DR   UniPathway; UPA00753; UER00740.
DR   PRO; PR:Q66H21; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000058271; Expressed in adult mammalian kidney and 18 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004142; F:diacylglycerol cholinephosphotransferase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016780; F:phosphotransferase activity, for other substituted phosphate groups; ISO:RGD.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; ISO:RGD.
DR   GO; GO:0006663; P:platelet activating factor biosynthetic process; ISO:RGD.
DR   Gene3D; 1.20.120.1760; -; 1.
DR   InterPro; IPR000462; CDP-OH_P_trans.
DR   InterPro; IPR043130; CDP-OH_PTrfase_TM_dom.
DR   InterPro; IPR048254; CDP_ALCOHOL_P_TRANSF_CS.
DR   InterPro; IPR014472; CHOPT.
DR   PANTHER; PTHR10414:SF32; CHOLINEPHOSPHOTRANSFERASE 1; 1.
DR   PANTHER; PTHR10414; ETHANOLAMINEPHOSPHOTRANSFERASE; 1.
DR   Pfam; PF01066; CDP-OH_P_transf; 1.
DR   PIRSF; PIRSF015665; CHOPT; 1.
DR   PROSITE; PS00379; CDP_ALCOHOL_P_TRANSF; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Golgi apparatus; Lipid biosynthesis; Lipid metabolism;
KW   Magnesium; Manganese; Membrane; Metal-binding; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WUD6"
FT   CHAIN           2..398
FT                   /note="Cholinephosphotransferase 1"
FT                   /id="PRO_0000289254"
FT   TOPO_DOM        2..62
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        63..83
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        84..93
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        94..118
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        119..125
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        126..150
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        151..160
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        161..179
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        180..190
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        191..207
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        208..222
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        223..248
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        249..265
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        266..281
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        282..293
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        294..316
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        317..329
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        330..339
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        340..346
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        347..376
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   TOPO_DOM        377..398
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   ACT_SITE        133
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         64
FT                   /ligand="CDP-choline"
FT                   /ligand_id="ChEBI:CHEBI:58779"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         111
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         111
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         114
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         119
FT                   /ligand="CDP-choline"
FT                   /ligand_id="ChEBI:CHEBI:58779"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         132
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         132
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   BINDING         136
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   SITE            129
FT                   /note="Increases basicity of active site His"
FT                   /evidence="ECO:0000250|UniProtKB:Q4KLV1"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WUD6"
SQ   SEQUENCE   398 AA;  44601 MW;  9A6A12BD69E107D9 CRC64;
     MAAGAGARPA PRWVKALGEP LSAAQLRRLE DHRYSAAGES LFEPPLQLFW TWLLQWIPLW
     IAPNTITLFG LAINLFTTLV LIFYCPTVTE EAPYWTYLLC ALGLFIYQSL DAIDGKQARR
     TNSCSPLGEL FDHGCDSLST VFMAIGASIA VRLGTHPDWL FFCSFVGMFM FYCAHWQTYV
     SGVLRFGRVD VTEIQVALVI VFLLSTFGGA MMWDYTIPIL EIKLKILPVL GVVGGLIFSC
     SNYFHVILHG GVGKNGSTIA GTSVLSPGLH IGLIIILAIM IYKKSATNVF EKHPCLYTLM
     FGCVFAKVAQ KLVIAHMTKS ELYLQDTVFI GPGLLFLDQY FNNFIDEYVV LWIAMVITSF
     DMMIYFSSLC LQISRHLHLS IFKTSYQQAP EQVHKHID
//
